Skip to content
ESE logo
ESE Award Winners 2027

  ESE Awards logo

We are delighted to announce the winners of the 2027 ESE Awards!  

The winners of the Society’s annual Awards have all excelled in endocrinology and made invaluable contributions to the field. Each of the winners will be presenting a plenary lecture at the European Congress of Endocrinology, which will be taking place 8–11 May 2027 in Basel, Switzerland, with the exception of the Transatlantic Alliance Award, which will be presented at the Endocrine Society's annual meeting, ENDO 2027. You can also find out more about each winner in the Spring issue of our Member Magazine ‘Endocrine Views’ out February 2027.  

 Geoffrey Harris Award Winner 2027  

The Geoffrey Harris Award recognises outstanding researchers in the field of neuroendocrinology. This year’s Award is being presented to Mone Zaidi.  

 Mone Zaidi is the Mount Sinai Endowed Professor of Clinical Medicine and Director of the Institute for Translational Medicine and Pharmacology at the Icahn School of Medicine at Mount Sinai and the Founding Director of The Mount Sinai Bone Program.  

For more than three decades, Dr. Zaidi has made influential discoveries on the mechanisms of skeletal homeostasis in health and disease. His studies include the first description of calcium sensing in the osteoclast and the discovery that locally released nitric oxide suppresses bone cells. In 2003, his laboratory published the first evidence for a pituitary-bone axis, a breakthrough in physiology showing that pituitary hormones act directly on the skeleton.  

In two groundbreaking papers in Nature, Dr. Zaidi found that inhibiting FSH not only increased bone mass but also reduced body fat and prevented neurodegeneration, in essence laying a firm foundation for a single anti-FSH agent to treat osteoporosis, obesity and Alzheimer’s disease. This work was selected by Nature Medicine as one of eight “Notable Advances” in biomedicine for 2017 and was editorialized in the New York Times.  

In addition to the 2027 Geoffrey Harris Award, his recent honours include the 2026 Jacobi Medallion (Mount Sinai’s highest honour), the 2025 William F. Neuman Award from the American Society for Bone and Mineral Research and the 2024 Harriet P. Dustan Award from the American College of Physicians (ACP). He is a Master of the ACP, a Fellow of the American Association for the Advancement of Science and of the National Academy of Inventors and the recipient of five honorary doctorates.  

Dr. Zaidi trained at King George’s Medical College, India, and Hammersmith Hospital, London, earned a PhD and MD from the University of London, and held faculty appointments in the UK and at the University of Arkansas for Medical Sciences, University of Pennsylvania and Medical College of Pennsylvania before joining Mount Sinai in 1999.  

Transatlantic Alliance Award winner 2027 

 The Transatlantic Alliance Award is presented to an international leader who has made significant advancements in endocrinology throughout the US and Europe. This award is presented on behalf of ESE and the Endocrine Society. The recipient of this award is Anders Juul.  

Anders Juul is a Professor of Paediatric Endocrinology at the University of Copenhagen and Head of the Department of Growth and Reproduction at Rigshospitalet (Copenhagen University Hospital) in Copenhagen, Denmark. He also is Coordinating Professor at the Juliane Marie Center, Rigshospitalet, and the Department of Clinical Medicine, University of Copenhagen. 

European Endocrine Nurse Award Winner 2027 

The European Endocrine Nurse Award is awarded to endocrine nurses and teams who have made a truly significant contribution to the advancement of endocrinology nursing. This year’s Award is presented to Sherwin Criseno. 

Sherwin Criseno is a Nurse Consultant in Endocrinology at University Hospitals Birmingham NHS Foundation Trust and an Honorary Associate Clinical Professor of Nursing at the University of Birmingham.  

He leads the largest specialist endocrinology nursing team in Europe and has special interest in pituitary and adrenal disorders, andrology, metabolic bone disease, and adult growth hormone deficiency. An NIHR Clinical Doctoral Research Fellow, his research focuses on the effects of growth hormone treatment discontinuation in adults. He is the first nurse appointed to the Board of Directors of the UK Society for Endocrinology and was recently awarded the Nursing Times Nurse Leader of the Year 2026. 

Clinical Endocrinology Journal Foundation Award Winner 2027 

The Clinical Endocrinology Journal Foundation Award is given for clinical research that addresses aspects of endocrinology at the forefront of clinical practice and is sponsored by the Clinical Endocrinology Journal Foundation. This year's Award goes to Stefanie Hahner.  

Stefanie Hahner is Professor of Endocrinology and Deputy Head of the Division of Endocrinology and Diabetology at University Hospital Würzburg, Germany. Her clinical and translational research focuses on adrenal disorders, particularly adrenal insufficiency and adrenal tumours.  

Her work aims to improve the clinical management and long-term outcomes of patients with adrenal insufficiency and to advance functional adrenal imaging for the personalized diagnosis and treatment of adrenal tumours. Additional research interests include chronic hypoparathyroidism. She is actively involved in the development of international clinical guidelines and structured patient education programmes. Previously serving as Vice Dean for Early Career Researchers, she remains committed to academic mentoring and supporting the next generation of researchers.  

European Journal of Endocrinology Award Winner 2027 

The European Journal of Endocrinology Award is presented to a candidate who has significantly contributed to the advancement of knowledge in the field of endocrinology through publication. This year’s Award goes to Svenja Nölting.  

Svenja Nölting is a board-certified specialist in Internal Medicine, Endocrinology, and Diabetology, appointed Assistant Professor for Endocrine Tumors and Senior Consultant at the Department of Endocrinology, Diabetology and Clinical Nutrition at the University Hospital Zurich (USZ) and the University of Zurich (UZH). She serves as clinical lead for endocrine tumour diseases and as Interdisciplinary Head of the Endocrine and Neuroendocrine Tumor Board and Tumor Center, ENETS Center of Excellence Zurich, Comprehensive Cancer Center Zurich (CCCZ).  

After completing her medical degree and doctoral thesis at Ludwig Maximilian University (LMU) Munich, she began her specialist training in Internal Medicine, Endocrinology, and Diabetology. She was awarded a prestigious research fellowship by the German Research Foundation (DFG) to investigate novel targeted therapies for malignant pheochromocytomas and paragangliomas, which led to postdoctoral research at leading international institutions, including Barts and the London School of Medicine and the National Institutes of Health (NIH).  

She subsequently continued her clinical and scientific career at LMU University Hospital, where she established an independent research profile focused on personalised therapy of endocrine tumours. In 2020, she was appointed Assistant Professor for Endocrine Tumors at USZ and UZH.  

Svenja Nölting is internationally recognized as a worldwide leading expert in the treatment of pheochromocytoma and paraganglioma. Her translational research centres on the molecular characterization and functional testing of human patient-derived endocrine tumour tissue to identify patient-specific therapeutic strategies and biomarkers.  

Her research is supported by major competitive funding bodies and foundations. She has an outstanding publication record in leading international peer-reviewed journals and contributes actively as reviewer and editor.  

She holds leading roles in international expert committees, in the development of consensus statements and clinical guidelines, and in the organisation of major international conferences, underscoring her global visibility and influence in endocrine oncology.  

Jens Sandahl Christiansen Award winners 2027 

The Jens Sandahl Christiansen Award is presented to endocrinologists for a specific piece of research or project which contributes to our understanding of metabolism. This award is split into clinical and basic science. The recipients of the Award for 2027 are Vasileios Chortis for Basic Science and Julie Refardt for Clinical.   

Basic Science Award

Vasileios Chortis is an MRC Clinician Scientist and Associate Clinical Professor of Endocrinology at the University of Birmingham, UK, and Honorary Consultant Endocrinologist at University Hospitals Birmingham. He completed his clinical training in Endocrinology at University Hospitals Birmingham and obtained his PhD from the University of Birmingham in 2017. He subsequently undertook a postdoctoral research fellowship at Boston Children’s Hospital and Harvard Medical School (2021–2024).  

His research focuses on the study of metabolic dysregulation in adrenal tumours, integrating preclinical disease models with clinical studies to advance translational discovery. His work aims to improve the molecular stratification of adrenal tumours, identify clinically actionable biomarkers, and develop novel targeted therapeutic strategies. He has co-authored over 30 peer-reviewed publications and has received several prestigious research fellowships and grants from the UK Medical Research Council, the Wellcome Trust, the UK Academy of Medical Sciences, and Harvard University.  

Clinical Award

Julie Refardt is an Assistant Professor and clinical researcher at the Department of Endocrinology, Erasmus MC, Rotterdam, the Netherlands. 

She studied medicine at the University of Basel, Switzerland, where she obtained her medical degree in 2009. She subsequently completed her specialist training in Internal Medicine in 2015 and Endocrinology in 2017.  

Her research career began in 2013 in the group of Professor Mirjam Christ-Crain, where she conducted investigator-initiated clinical trials focusing on disorders of water and sodium balance. Her work contributed to several high-impact publications, particularly in the fields of arginine vasopressin (AVP) deficiency and hyponatremia.  

In 2019, she broadened her research focus by joining Erasmus MC in Rotterdam, where she spent two years advancing her expertise in neuroendocrinology. This experience laid the foundation for her PhD, which she obtained from Erasmus University Rotterdam in 2023. Following a brief return to Switzerland, she relocated to the Netherlands in 2023 to join Erasmus MC as a medical specialist and clinical researcher.  

Driven by a strong interest in neuroendocrinology, her research focuses on advancing the diagnosis and treatment of patients with neuroendocrine disorders. Beyond her research activities, she contributes to the development of international clinical practice guidelines as a member of the joint European Society of Endocrinology (ESE)/European Renal Association (ERA) hyponatremia guideline group and the ESE/Endocrine Society guideline committee on AVP deficiency.  

Congratulations to Our Winners

We would like to congratulate all our award winners for their outstanding achievements in endocrinology. We are proud to celebrate their success and would like to extend a sincere thank you to everyone who took their time to submit a nomination to help recognise the incredible work taking place across the endocrine community. Nominations for the 2028 ESE Awards will open in Spring 2027.